# Ranolazine

## Rancad 500mg extended release

##### 

| 藥品代碼   | ORANC                                                                                                                                                                                                                                                                                                                                |
|:-----------|:-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 適應症     | Stable angina.                                                                                                                                                                                                                                                                                                                       |
| 用法用量   | Oral: Initial: 500 mg twice daily; may increase to 1000 mg twice daily as needed (based on symptoms); maximum recommended dose: 1000 mg twice daily.                                                                                                                                                                                 |
| 肝功能異常 | 需調整劑量                                                                                                                                                                                                                                                                                                                           |
| 腎功能異常 | 需調整劑量                                                                                                                                                                                                                                                                                                                           |
| 禁忌       | Concurrent use of CYP3A inducers， such as rifampin， rifabutin， rifapentine， phenobarbital， phenytoin， carbamazepine， and St John's wort. Concurrent use of strong CYP3A inhibitors such as ketoconazole， itraconazole， clarithromycin， nefazodone， nelfinavir， ritonavir， indinavir， and saquinavir. Hepatic cirrhosis |
| 副作用     | Common Gastrointestinal: Constipation (4.5% )， Nausea (4.4% ) Neurologic: Dizziness (6.2% )， Headache (5.5% ) Serious Cardiovascular: Prolonged QT interval， Vasovagal syncope (0.5% to 4% )                                                                                                                                      |
| 孕期建議   | No (limited) human data – animal data suggest risk                                                                                                                                                                                                                                                                                   |
| 哺乳期建議 | No (Limited) Human Data - Potential Toxicity 無(很少)資料 - 避免使用                                                                                                                                                                                                                                                                 |

